Jane Street Group, LLC Arvinas, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	BUY	$65.85 - $96.21 $322,665 - $471,428	4,900 Added 27.84%	22,500 $1.85 Million
Q3 2021 Nov 16, 2021	BUY	$73.2 - $107.87 $307,440 - $453,054	4,200 Added 31.34%	17,600 $1.45 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $816,075 - $1.14 Million	-13,500 Reduced 50.19%	13,400 $1.03 Million
Q1 2021 May 18, 2021	SELL	$58.19 - $91.37 $2.1 Million - $3.3 Million	-36,100 Reduced 57.3%	26,900 $1.78 Million
Q4 2020 Feb 17, 2021	BUY	$20.19 - $84.93 $1.27 Million - $5.35 Million	63,000 New	63,000 $5.35 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.38B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.